Detalhe da pesquisa
1.
Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(5): 757-766, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28219835
2.
Should a Stoma Be Used After Intestinal Transplant.
Gastroenterol Clin North Am
; 53(2): 299-308, 2024 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719380
3.
Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.
Front Immunol
; 12: 636789, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33737937
4.
Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models.
JCI Insight
; 3(20)2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333311
5.
Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta.
Matrix Biol
; 24(7): 451-8, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16095890
6.
Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages.
J Biol Chem
; 281(18): 12888-95, 2006 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16492673
7.
Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim).
Kidney Int
; 62(2): 383-91, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12109999